Tilray Q1 2025 Earnings Report
Key Takeaways
Tilray Brands reported a 13% year-over-year revenue growth, reaching a record $200 million in net revenue for Q1 2025. The company's gross margin increased by over 500 basis points, representing a 20% year-over-year growth. Tilray Beverages experienced a 132% net revenue growth, and German medical cannabis flower revenue increased by 50% following legalization.
Tilray Brands achieved 13% year-over-year revenue growth.
Record Q1 net revenue of $200 million was generated.
Gross margin increased over 500 basis points, a 20% year-over-year growth.
Tilray Beverages net revenue grew by 132%.
Tilray
Tilray
Forward Guidance
Tilray anticipates improved regulatory changes in the cannabis industry following the upcoming U.S. Presidential elections, with both candidates expressing support for further legalization. The company is optimistic about future opportunities in the cannabis industry.
Positive Outlook
- Anticipates improved regulatory changes in the cannabis industry following the upcoming U.S. Presidential elections.
- Both candidates have publicly confirmed their support for further legalization.
- Optimistic about the future of the cannabis industry.
- Dedicated to executing strategic plan to increase revenue.
- Dedicated to executing strategic plan to drive operational efficiencies, and improve margins and profitability